Total Payments
$17,074
2024 Payments
$1,253
Companies
36
Transactions
741
Medicare Patients
11,660
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$16,605 (97.3%)
Education$468.85 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,605 | 733 | 97.3% |
| Education | $468.85 | 8 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,340 | 211 | $0 (2024) |
| Janssen Biotech, Inc. | $1,616 | 63 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,349 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,224 | 53 | $0 (2024) |
| Merz North America, Inc. | $993.26 | 7 | $0 (2019) |
| Amgen Inc. | $965.68 | 38 | $0 (2024) |
| Lilly USA, LLC | $956.22 | 52 | $0 (2024) |
| Celgene Corporation | $738.92 | 22 | $0 (2019) |
| PFIZER INC. | $676.72 | 44 | $0 (2024) |
| DUSA Pharmaceuticals, Inc. | $660.85 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,253 | 61 | ABBVIE INC. ($374.75) |
| 2023 | $2,600 | 106 | ABBVIE INC. ($846.56) |
| 2022 | $2,251 | 113 | ABBVIE INC. ($949.21) |
| 2021 | $1,865 | 106 | AbbVie Inc. ($460.55) |
| 2020 | $1,069 | 55 | AbbVie Inc. ($271.40) |
| 2019 | $2,621 | 98 | AbbVie, Inc. ($677.65) |
| 2018 | $2,731 | 88 | Merz North America, Inc. ($617.59) |
| 2017 | $2,685 | 114 | DUSA Pharmaceuticals, Inc. ($594.44) |
All Payment Transactions
741 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.83 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.77 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/18/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.83 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $104.99 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.37 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.27 | General |
| 09/18/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.73 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.40 | General |
| Category: Dermatology | ||||||
| 08/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,356 | 6,072 | $646,159 | $406,299 |
| 2022 | 35 | 2,520 | 6,749 | $688,630 | $468,816 |
| 2021 | 37 | 3,091 | 7,291 | $523,985 | $375,375 |
| 2020 | 41 | 3,693 | 8,182 | $606,503 | $426,690 |
Total Patients
11,660
Total Services
28,294
Medicare Billing
$1.7M
Procedure Codes
147
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 77 | 567 | $159,791 | $112,929 | 70.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 666 | 1,526 | $154,582 | $88,982 | 57.6% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 78 | 278 | $52,662 | $37,157 | 70.6% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 76 | 90 | $43,742 | $29,776 | 68.1% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 80 | 994 | $42,535 | $29,460 | 69.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 126 | 163 | $30,549 | $18,011 | 59.0% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 75 | 103 | $17,017 | $9,457 | 55.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 104 | 104 | $12,469 | $6,876 | 55.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 72 | $10,014 | $6,627 | 66.2% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 71 | 88 | $13,506 | $6,578 | 48.7% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 75 | 96 | $12,517 | $6,469 | 51.7% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 64 | 83 | $12,213 | $6,098 | 49.9% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 57 | 113 | $8,863 | $4,893 | 55.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 44 | $8,483 | $4,700 | 55.4% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 48 | 57 | $8,812 | $4,431 | 50.3% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 27 | 30 | $6,581 | $4,261 | 64.7% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 76 | 86 | $6,008 | $4,253 | 70.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 80 | 86 | $6,123 | $3,427 | 56.0% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 23 | 25 | $4,767 | $3,007 | 63.1% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 38 | 40 | $5,268 | $2,867 | 54.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $3,957 | $2,343 | 59.2% |
| 11313 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, more than 2.0 cm | Office | 2023 | 15 | 17 | $3,283 | $2,185 | 66.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 44 | 57 | $3,442 | $1,990 | 57.8% |
| 11303 | Shaving of skin growth of body, arms, or legs, more than 2.0 cm | Office | 2023 | 16 | 19 | $3,101 | $1,562 | 50.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 19 | $2,945 | $1,376 | 46.7% |
About Dr. Andrew Hendricks, MD
Dr. Andrew Hendricks, MD is a Dermatology healthcare provider based in Lumberton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740246115.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Hendricks, MD has received a total of $17,074 in payments from pharmaceutical and medical device companies, with $1,253 received in 2024. These payments were reported across 741 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($16,605).
As a Medicare-enrolled provider, Hendricks has provided services to 11,660 Medicare beneficiaries, totaling 28,294 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 147 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology
- Location Lumberton, NC
- Active Since 04/25/2006
- Last Updated 03/07/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1740246115
Products in Payments
- RINVOQ (Biological) $1,398
- Otezla (Drug) $1,354
- TREMFYA (Drug) $1,087
- COSENTYX (Biological) $1,014
- SKYRIZI (Biological) $1,011
- Humira (Biological) $833.12
- TALTZ (Drug) $758.30
- EUCRISA (Drug) $676.72
- Levulan (Drug) $594.44
- DUPIXENT (Biological) $534.52
- ILUMYA (Biological) $506.46
- XEOMIN (Biological) $385.38
- HUMIRA (Biological) $346.90
- Skyrizi (Biological) $326.61
- SPEVIGO (Drug) $293.86
- REMICADE (Biological) $274.02
- Ilumya (Biological) $267.72
- Enbrel (Biological) $262.10
- Xolair (Biological) $222.72
- DUPIXENT DUPILUMAB INJECTION (Biological) $219.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.